Trial Details

TERMINATED
Basic Information
Clinical ID c4648
Identifier NCT00206713
Trial Title Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: Sargramostim (Leukine)|DRUG: Placebo
Participant Information
Sponsor Genzyme, a Sanofi Company
City San Francisco
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2004-07
Primary Completion Date 2006-10
Completion Date 2006-10